Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates

Standard BioTools (LAB) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 37.50%. A quarter ago, it was expected that this company that makes equipment to control fluids would post a loss of $0.06 per share when it actually produced a loss of $0.08, delivering a surprise of -33.33%. Over the l ...